Prostate Risk Index (PRIX) as a New Method of Risk Classification for Clinically Localized Prostate Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Link
http://link.springer.com/content/pdf/10.1007/s00066-007-1692-3.pdf
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer;Frontiers in Oncology;2024-02-27
2. Evaluation of four pre‐operative models for prediction of biochemical recurrence after radical prostatectomy in localised prostate cancer;International Journal of Clinical Practice;2021-08-06
3. Comparison of Acute and Subacute Genitourinary and Gastrointestinal Adverse Events of Radiotherapy for Prostate Cancer Using Intensity-modulated Radiation Therapy, Three-dimensional Conformal Radiation Therapy, Permanent Implant Brachytherapy and High-dose-rate Brachytherapy;Tumori Journal;2014-05
4. Pre-treatment risk stratification of prostate cancer patients: A critical review;Canadian Urological Association Journal;2012-04-17
5. Validation of the Prostate Cancer Risk Index (PRIX): A Simple Scoring System to Predict Risk of Biochemical Relapse after Radical Prostatectomy for Prostate Cancer;Japanese Journal of Clinical Oncology;2011-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3